Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: A population-based study

AIDS

Volumn 28, Issue 15, 2014, Pages 2313-2318

  Gibson, Todd M ^c   Morton, Lindsay M ^a   Shiels, Meredith S ^a   Clarke, Christina A ^b   Engels, Eric A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

AIDS; AIDS related; Epidemiology; HIV; Lymphoma; Non hodgkin lymphoma

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; AIDS PATIENT; ARTICLE; CANCER RISK; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOBLASTOMA; MAJOR CLINICAL STUDY; MARGINAL ZONE LYMPHOMA; NONHODGKIN LYMPHOMA; POPULATION RESEARCH; PRIORITY JOURNAL; REGISTER; STANDARDIZED INCIDENCE RATIO; T CELL LYMPHOMA; WALDENSTROEM MACROGLOBULINEMIA; COMPLICATION; HIV INFECTIONS; INCIDENCE; LYMPHOMA, NON-HODGKIN; PATHOLOGY; PROCEDURES; RISK ASSESSMENT; UNITED STATES;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; INCIDENCE; LYMPHOMA, NON-HODGKIN; RISK ASSESSMENT; UNITED STATES;

EID: 84927911234     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000428     Document Type: Article

References (22)

1. Centers for Disease Control and Prevention. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. MMWR Morb Mortal Wkly Rep 1987; 36 (Suppl 1):1S-15S.
2. Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA, Study HACM. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst 2007; 99:962-972.
3. Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 2008; 123:187- 194.
4. Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 2006; 20:1645-1654.
5. van Leeuwen MT, Vajdic CM, Middleton MG, McDonald AM, Law M, Kaldor JM, et al. Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy. AIDS 2009; 23:2183-2190.
6. Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H, et al. WHO Classification of tumours of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer; 2008.
7. Althoff KN, Buchacz K, Hall HI, Zhang J, Hanna DB, Rebeiro P, et al. U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIVinfected persons, 2000 to 2008. Ann Intern Med 2012; 157:325-335.
8. Guech-Ongey M, Simard EP, Anderson WF, Engels EA, Bhatia K, Devesa SS, et al. AIDS-related Burkitt lymphoma in the United States: What do age and CD4 lymphocyte patterns tell us about etiology and/or biology? Blood 2010; 116:5600-5604.
9. Biggar RJ, Engels EA, Frisch M, Goedert JJ, Group ACMRS. Risk of T-cell lymphomas in persons with AIDS. J Acquir Immune Defic Syndr 2001; 26:371-376.
10. Manasanch EE, Kristinsson SY, Landgren O. Etiology of Waldenstrom macroglobulinemia: genetic factors and immune-related conditions. Clin Lymphoma Myeloma Leuk 2013; 13:194-197.
11. Suarez F, Lortholary O, Hermine O, Lecuit M. Infection-associated lymphomas derived from marginal zone B cells: A model of antigen-driven lymphoproliferation. Blood 2006; 107:3034- 3044.
12. Anderson LA, Gadalla S, Morton LM, Landgren O, Pfeiffer R, Warren JL, et al. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer 2009; 125:398-405.
13. Chang CM, Quinlan SC, Warren JL, Engels EA. Blood transfusions and the subsequent risk of hematologic malignancies. Transfusion 2010; 50:2249-2257.
14. Morton LM, Gibson TM, Clarke CA, Lynch CF, Weisenburger DD, Engels EA. Hepatitis B or C virus infection and risk of non- Hodgkin lymphoma among solid organ transplant recipients. Haematologica 2014; 99:70-73.
15. Engels EA, Frisch M, Lubin JH, Gail MH, Biggar RJ, Goedert JJ. Prevalence of hepatitis C virus infection and risk for hepatocellular carcinoma and non-Hodgkin lymphoma in AIDS. J Acquir Immune Defic Syndr 2002; 31:536-541.
16. Levine AM, Nelson R, Zuckerman E, Zuckerman T, Govindarajan S, Valinluck B, et al. Lack of association between hepatitis C infection and development of AIDS-related lymphoma. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20:255-258.
17. Vajdic CM, van Leeuwen MT, Turner JJ, McDonald AM, Webster AC, McDonald SP, et al. No excess risk of follicular lymphoma in kidney transplant and HIV-related immunodeficiency. Int J Cancer 2010; 127:2732-2735.
18. Clarke CA, Morton LM, Lynch C, Pfeiffer RM, Hall EC, Gibson TM, et al. Risk of lymphoma subtypes after solid organ transplantation in the United States. Br J Cancer 2013; 109:280-288.
19. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: A meta-analysis. Lancet 2007; 370:59-67.
20. Shiels MS, Engels EA, Linet MS, Clarke CA, Li J, Hall HI, et al. The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992-2009. Cancer Epidemiol Biomarkers Prev 2013; 22:1069-1078.
21. Chaturvedi AK, Mbulaiteye SM, Engels EA. Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers. Ann Epidemiol 2008; 18:230-234.
22. Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data: United States and 6 dependent areas: 2011. HIV Surveillance Suppl Rep 2013; 18.